Home › Funds › Brevan Howard Capital Management LP › CME
Brevan Howard Capital Management LP position in CME
CME GROUP INC · Financials
Brevan Howard Capital Management LP reported holding 107,048 shares of CME (CME GROUP INC) in its Q2 2026 13F filing — a position valued at US$23.6M, representing 0.34% of its reported portfolio and ranking #33 among its reported holdings. Brevan Howard Capital Management LP has disclosed CME holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Brevan Howard Capital Management LP's CME position evolved
Brevan Howard Capital Management LP first disclosed a stake in CME in Q3 2023 at 102,553 shares (US$20.5M). The position peaked in Q2 2025 at 174,716 shares, worth US$48.2M. Across 11 filings, Brevan Howard Capital Management LP increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 107,048 shares valued at US$23.6M — an increase of 4,342 shares quarter over quarter.. Notable position changes include a 63% increase in Q2 2025 (shares fell 2% over the following quarter), a 40% trim in Q3 2025 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 102.55K | $20.53M | New |
| Q1 2024 | 102.55K | $22.08M | New |
| Q2 2024 | 112.30K | $22.08M | Add |
| Q3 2024 | 119.65K | $26.40M | Add |
| Q4 2024 | 104.21K | $24.20M | Reduce |
| Q1 2025 | 107.28K | $28.46M | Add |
| Q2 2025 | 174.72K | $48.16M | Add |
| Q3 2025 | 105.58K | $28.53M | Reduce |
| Q4 2025 | 111.95K | $30.57M | Add |
| Q1 2026 | 102.71K | $30.33M | Reduce |
| Q2 2026 | 107.05K | $23.64M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CME and 13F data
CME (CME GROUP INC) is a Financials company. 27 other funds we track also report a position in CME — the largest reported positions include Banque Cantonale Vaudoise (US$3.33B), Sanders Capital, LLC (US$1.12B), RAYMOND JAMES FINANCIAL INC (US$896.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CME
- Banque Cantonale Vaudoise 15.09K sh · $3.33B · Q2 2026
- Sanders Capital, LLC 5.07M sh · $1.12B · Q2 2026
- RAYMOND JAMES FINANCIAL INC 4.06M sh · $896.03M · Q2 2026
- Fidelity International (FIL) 4.00M sh · $883.86M · Q2 2026
- Alphabet Inc. 3.48M sh · $769.38M · Q2 2026
- ROYAL BANK OF CANADA 3.28M sh · $725.35M · Q2 2026
- Capital Wealth Planning, LLC 3.22M sh · $711.67M · Q2 2026
- PineStone Asset Management Inc. 2.61M sh · $683.81M · Q3 2026
More on Brevan Howard Capital Management LP
FAQ
How long has Brevan Howard Capital Management LP held CME?
Brevan Howard Capital Management LP has disclosed CME holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is Brevan Howard Capital Management LP's current position in CME?
As of Q2 2026, Brevan Howard Capital Management LP holds 107.05K shares of CME (CME GROUP INC), valued at $23.64M, representing 0.34% of its reported portfolio and ranking #33.
Has Brevan Howard Capital Management LP been buying or selling CME?
In the latest 13F filing (Q2 2026), Brevan Howard Capital Management LP increased its position in CME. The position peaked in Q2 2025 at 174.72K shares.
Which other funds hold CME?
Other major institutional holders of CME include Banque Cantonale Vaudoise, Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.